Amgen Inc (AMGN)

248.39
+0.04(+0.02%)
After Hours
247.28
-1.11(-0.45%)
- Real-time Data
  • Volume:
    3,458,880
  • Day's Range:
    246.30 - 249.85
  • 52 wk Range:
    198.64 - 258.45

AMGN News

Prev. Close
248.35
Day's Range
246.3-249.85
Revenue
26.38B
Open
248.52
52 wk Range
198.64-258.45
EPS
11.89
Volume
3,458,880
Market Cap
132.87B
Dividend (Yield)
7.76
(3.12%)
Average Volume (3m)
3,000,482
P/E Ratio
21.01
Beta
0.56
1-Year Change
8.15%
Shares Outstanding
534,930,850
Next Earnings Date
Nov 01, 2022
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Amgen Inc Analysis

Amgen Inc Company Profile

Amgen Inc Company Profile

Employees
24300

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellStrong SellBuyStrong Buy